AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
66 hedge funds and large institutions have $30.5M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
18
Reduced
11
Closed
7
Calls
$246K
Puts
$143K
Net Calls
+$103K
Net Calls Change
-$118K
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.82M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.8M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$901K |
| 4 |
FM
4
Family Management
New York
|
$139K |
| 5 |
5
Millennium Management
New York
|
$79K |
